Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405899 · ClinicalTrials.gov registry record
Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
A clinical trial, sponsored by West Penn Allegheny Health System.
- Completed
- Registry status
- 20
- Enrollment target
NCT00405899: Completed study, sponsored by West Penn Allegheny Health System.
NCT00405899 is a clinical trial that has completed, run by West Penn Allegheny Health System. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00405899 has completed, sponsored by West Penn Allegheny Health System.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether there is a relationship between interferon-gamma levels and the incidence of viral respiratory infections in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care (nasal steroids, antihistamines) over a 1-year period. The hypotheses to be tested are 1) interferon-gamma levels will be significantly increased 3, 6, 9 and 12 months in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care, 2) the incidence of viral respiratory infections will be reduced at 3, 6, 9 and 12 months in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-12 |
What the finished NCT00405899 record still lists
NCT00405899 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00405899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00405899 about?
NCT00405899 is a clinical study titled "Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections". The objective of this study is to determine whether there is a relationship between interferon-gamma levels and the incidence of viral respiratory infections in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care (nasal steroids, antihistamine...
What is the current status of trial NCT00405899?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2006-10. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00405899?
This trial is sponsored by West Penn Allegheny Health System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia